BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1801330)

  • 1. Global inequalities in cancer care.
    Olweny CL
    Trans R Soc Trop Med Hyg; 1991; 85(6):709-10. PubMed ID: 1801330
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical cancer: treatment challenges in the developing world.
    Thomas G
    Radiother Oncol; 2006 May; 79(2):139-41. PubMed ID: 16684573
    [No Abstract]   [Full Text] [Related]  

  • 3. Cervical cancer in the Third World.
    Davy M
    Cent Afr J Med; 1987 May; 33(5):133-4. PubMed ID: 3450402
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
    Sankaranarayanan R
    Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S205-10. PubMed ID: 17161159
    [No Abstract]   [Full Text] [Related]  

  • 5. Making the Best Use of Resources in Global Cancer Care.
    Gago J; Pendharkar D; Tripathi C; Ginsburg O
    Am Soc Clin Oncol Educ Book; 2020 May; 40():e361-e366. PubMed ID: 32614655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional variations in primary liver cancer in ivory Coast.
    Tuyns AJ; Loubière R; Duvenet-Battesti F
    J Natl Cancer Inst; 1971 Jul; 47(1):131-5. PubMed ID: 4328190
    [No Abstract]   [Full Text] [Related]  

  • 7. [Model of a program for the prevention and detection of gynecologic cancer in developing countries].
    Goes Júnior JS; Goes JC
    AMB Rev Assoc Med Bras; 1980 Dec; 26(12):411-6. PubMed ID: 6973785
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis.
    Forouzanfar MH; Foreman KJ; Delossantos AM; Lozano R; Lopez AD; Murray CJ; Naghavi M
    Lancet; 2011 Oct; 378(9801):1461-84. PubMed ID: 21924486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer in Braazzaville, the Congo.
    Tuyns AJ; Ravisse P
    J Natl Cancer Inst; 1970 May; 44(5):1121-7. PubMed ID: 5514472
    [No Abstract]   [Full Text] [Related]  

  • 10. HPV vaccine for prevention of cervical cancer: key issues and challenges for developing countries.
    JNMA J Nepal Med Assoc; 2009; 48(175):I-II. PubMed ID: 20795456
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inverse equity hypothesis: does it apply to coverage of cancer screening in middle-income countries?
    Lee JT; Huang Z; Basu S; Millett C
    J Epidemiol Community Health; 2015 Feb; 69(2):149-55. PubMed ID: 25311479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccines to prevent cervical cancer.
    Markman M
    Lancet; 2007 Jun; 369(9576):1837-1839. PubMed ID: 17544748
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inequalities in cervical screening practices].
    Döbrőssy L; Kovács A; Budai A
    Orv Hetil; 2015 Jun; 156(24):955-63. PubMed ID: 26051131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of cervical precancers: a global perspective.
    Echelman D; Feldman S
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):31-44. PubMed ID: 22244660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of cancer of the cervix in low- and middle-income countries.
    Denny L
    Ann Surg Oncol; 2015 Mar; 22(3):728-33. PubMed ID: 25605513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer prevention and control in developing countries: a model program.
    Goes JS; Goes JC
    Bull Pan Am Health Organ; 1981; 15(3):216-25. PubMed ID: 7306733
    [No Abstract]   [Full Text] [Related]  

  • 18. Ten years of collaboration in Honduras.
    Chuang LT
    Int J Gynecol Cancer; 2019 Jul; 29(6):1082. PubMed ID: 31076450
    [No Abstract]   [Full Text] [Related]  

  • 19. Status of HPV vaccine introduction and barriers to country uptake.
    Gallagher KE; LaMontagne DS; Watson-Jones D
    Vaccine; 2018 Aug; 36(32 Pt A):4761-4767. PubMed ID: 29580641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global reduction of cervical cancer with human papillomavirus vaccines: insights from the hepatitis B virus vaccine experience.
    Heffernan ME; Garland SM; Kane MA
    Sex Health; 2010 Sep; 7(3):383-90. PubMed ID: 20719231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.